(Q58610647)
Statements
Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common variable immunodeficiency (English)
Riccardo De Carli
Rossano Girometti
Alessandro De Pellegrin
Federico Reccardini
Barbara Frossi